Price: £95 PLUS VAT
Format: DOWNLOADABLE PDF
***Full-scale policy conference taking place online***
This conference will consider priorities for the life sciences sector, options for utilising funding, and what is needed for driving competitiveness.
It will be an opportunity to discuss the recent publication of the Life Sciences Vision, which sets out the Government and life sciences sector’s ambitions for the next 10 years, and aims to encapsulate the sector’s successful developments during the pandemic to take them forward and apply them to other major health challenges, with £200m of funding announced through a Life Sciences Investment Programme.
Areas of focus include:
- how to improve competitiveness for the sector following Brexit and the pandemic
- opportunities for expansion going forward, with the introduction of the ARIA
- options and priorities for supporting growth and innovation in the sector, as well as tackling barriers
- what has been learned from the process of life sciences research during the pandemic
We are pleased to be able to include keynote sessions with Dr Nicole Mather, Non-Executive Director, Health Research Authority; and Executive Partner and Life Sciences Lead, IBM; and Dr Richard Torbett, Chief Executive, The Association of the British Pharmaceutical Industry - as well as contributions from NICE; The Association for Clinical Biochemistry and Laboratory Medicine (ACB); BIVDA; the British Science Association; Deepbridge Capital; LifeArc; iMATCH (Innovate Manchester Advanced Therapy Centre Hub); MHRA; and the Northern Health Science Alliance.
The agenda will bring out latest thinking on:
- policy - progress in the Life Sciences Industrial Strategy, and next steps for the sector following proposals set out in the Queen’s Speech
- investment and infrastructure - priorities for development to boost UK competitiveness
- international collaboration - opportunities following the UK leaving the EU
- wider impact of health research - supporting growth and innovation in the sector to meet ambitions across health and social care, including improving access
Our forums are known for attracting strong interest from policymakers and stakeholders. Places have been reserved by parliamentary pass-holders from The Parliamentary Office of Science and Technology and officials from BEIS; the Cabinet Office; the Department for International Trade; the Department of Health and Social Care; the Government Office for Science; the Intellectual Property Office; the Medicines and Healthcare products Regulatory Agency; the Office for Life Sciences; The Scottish Government and the Welsh Government. Also due to attend are representatives from AstraZeneca; Bird & Bird; Boehringer Ingelheim; Clarion Solicitors; Creative Places; FarmaTrust; Great Western Hospitals NHS Foundation Trust; Illumina Cambridge; Imperial College London; M&F Health; McKesson; Medicines Discovery Catapult; National Institute for Health Research; OpenCell; Organon; PerkinElmer; Pfizer; Phil Collis; Rare Autoinflammatory Conditions Community; Res Consortium; Roche Diagnostics; Teesside University; University of Kent; Vertex Pharmaceuticals and Yorkshire & Humber Academic Health Science Network.
Press passes have been reserved by representatives from APM Health Europe and POLITICO.
This is a full-scale conference taking place online***
- full, four-hour programme including comfort breaks - you’ll also get a full recording and transcript to refer back to
- information-rich discussion involving key policymakers and stakeholders
- conference materials provided in advance, including speaker biographies
- speakers presenting via webcam, accompanied by slides if they wish, using the Cisco WebEx professional online conference platform (easy for delegates - we’ll provide full details)
- opportunities for live delegate questions and comments with all speakers
- a recording of the addresses, all slides cleared by speakers, and further materials, is made available to all delegates afterwards as a permanent record of the proceedings
- delegates are able to add their own written comments and articles following the conference, to be distributed to all attendees and more widely
- networking too - there will be opportunities for delegates to e-meet and interact - we’ll tell you how!
Full information and guidance on how to take part will be sent to delegates before the conference